Amedisys, Inc. (NASDAQ:AMED) Shares Acquired by State of Alaska Department of Revenue

State of Alaska Department of Revenue increased its stake in Amedisys, Inc. (NASDAQ:AMED) by 448.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,737 shares of the health services provider’s stock after acquiring an additional 16,955 shares during the period. State of Alaska Department of Revenue owned approximately 0.06% of Amedisys worth $1,882,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of AMED. Retirement Systems of Alabama increased its position in shares of Amedisys by 0.5% in the 4th quarter. Retirement Systems of Alabama now owns 39,822 shares of the health services provider’s stock valued at $3,615,000 after purchasing an additional 181 shares during the last quarter. Calamos Advisors LLC grew its stake in shares of Amedisys by 22.7% during the fourth quarter. Calamos Advisors LLC now owns 487,444 shares of the health services provider’s stock worth $44,255,000 after purchasing an additional 90,097 shares in the last quarter. R Squared Ltd purchased a new position in Amedisys in the fourth quarter valued at $203,000. Pacer Advisors Inc. raised its stake in Amedisys by 11,621.9% in the fourth quarter. Pacer Advisors Inc. now owns 558,197 shares of the health services provider’s stock valued at $50,679,000 after buying an additional 553,435 shares in the last quarter. Finally, KBC Group NV lifted its holdings in Amedisys by 76.8% during the 4th quarter. KBC Group NV now owns 1,158 shares of the health services provider’s stock worth $105,000 after buying an additional 503 shares during the last quarter. 94.36% of the stock is currently owned by hedge funds and other institutional investors.

Amedisys Trading Up 0.5 %

AMED opened at $92.52 on Wednesday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. Amedisys, Inc. has a one year low of $82.15 and a one year high of $98.95. The company has a market cap of $3.03 billion, a P/E ratio of 36.71, a PEG ratio of 1.82 and a beta of 0.73. The business’s 50-day simple moving average is $89.66 and its 200-day simple moving average is $93.69.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.